Biologic Drugs

Mar 29, 2018
By Pharmaceutical Technology Editors
The companies will co-develop and co-promote a CAR-T cell therapy in the United States.
Mar 27, 2018
By Pharmaceutical Technology Editors
Major countries will be ranked based on the potential for biopharma market growth, innovation, and competitiveness.
Mar 26, 2018
By Pharmaceutical Technology Editors
The agreement gives IncoCell Tianjin, a wholly-owned subsidiary of China-based Boyalife Group, access to Cesca’s celluar processing contract development and manufacturing services.
Mar 26, 2018
By Pharmaceutical Technology Editors
Hitachi will manufacture regenerative medicines developed by Daiichi Sankyo and SanBio Group.
Mar 23, 2018
By Pharmaceutical Technology Editors
The collaboration between the two companies aims to finish all necessary work needed to file for a first-in-human study by early 2019.
Mar 22, 2018
By Pharmaceutical Technology Editors
The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.
Mar 19, 2018
By Pharmaceutical Technology Editors
Sartorius Stedim Biotech has launched a new automated parallel bioreactor system for perfusion culture.
Mar 08, 2018
By Pharmaceutical Technology Editors
Under this agreement, the companies will develop in parallel an antibody drug candidate and cell lines for other potential candidates.
Mar 08, 2018
By Pharmaceutical Technology Editors
GlobalData reports the need to shift away from egg-based manufacturing of vaccines in light of influenza-related deaths.
Mar 06, 2018
By Pharmaceutical Technology Editors
The pharma major will spin out six molecules in early stage inflammation and autoimmune programs into a new company called Viela Bio.
native1_300x100
lorem ipsum